PSI ToxSIG Webinar: Beyond the looking glass - Interpreting animal welfare & behaviour by monitoring & assessing mice activity data
Analysing continuously collected locomotive activity data to interpret mice welfare and behaviour.
For this joint event with the DIA, Andreas Sashegyi and Sara Hughes presented their work on decision making at interims and DMCs.
Joint PSI Pharmaceutical Statistics & DIA Statistics Community
DIA Chair: Susan Duke, Manager, Benefit Risk Evaluation, GSK
Speaker: Andreas Sashegyi, Research Advisor, Decision Sciences Lilly Corporate Center, Lilly
A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
Andreas Sashegyi
Drug Information Journal, Vol. 45, pp. 749-757, 2011
Abstract | Paper+ | Slides
PSI Chair: Katherine Hutchinson, Head of Consultancy, Quanticate
Speaker: Sara Hughes, VP, Clinical Statistics, GSK
Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial
Sara Hughes, Robert L. Cuffe, Alfons Lieftucht and W. Garrett Nichols
Pharmaceutical Statistics, Vol. 8, Issue 1, pp. 25-37, 2009
Abstract | Paper+ | Slides
Discussant: Lisa LaVange, Director, Office of Biostatistics in the Office of Translational Sciences, FDA